Product Information
IBUPROFEN-FAMOTIDIN 800-26.6 MG is a generic product labeled by Ascend Laboratories, LLC, priced at $0.7693 per EA under NDC 67877062690. Its NADAC has been published 235 times since Feb 23, 2022.
FDA first approved this application on Aug 3, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
26.6; 800 mg/1; mg/1
Manufacturer
Ascend Laboratories, LLCNDC
67877062690
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
FAMOTIDINE; IBUPROFENApproval Type
Generic (ANDA)
FDA Application
ANDA211890FDA Approved
8/3/2021
TE Code
AB
On Market Since
8/4/2021
Pharmacological Classes
Price Statistics
The NADAC for IBUPROFEN-FAMOTIDIN 800-26.6 MG has been published 235 times since Feb 23, 2022, and over the history we have for it it has declined 79.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7693 per EA |
|---|---|
| All-time high | $4.1664 (Nov 16, 2022) |
| All-time low | $0.6418 (Feb 18, 2026) |
| 52-week high | $1.0176 |
| 52-week low | $0.6418 |
| Median price | $1.6750 |
| Average price | $2.0498 |
| Largest weekly change | +71.1% (Aug 23, 2023) |
| Weeks tracked | 235 |
| Tracking since | Feb 23, 2022 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of IBUPROFEN-FAMOTIDIN 800-26.6 MG?
The current National Average Drug Acquisition Cost (NADAC) for IBUPROFEN-FAMOTIDIN 800-26.6 MG, manufactured by Ascend Laboratories, LLC, is $0.7693 per EA (NDC 67877062690), effective Aug 19, 2026.
How has the price of IBUPROFEN-FAMOTIDIN 800-26.6 MG changed over time?
Over the history we have for it, the NADAC for IBUPROFEN-FAMOTIDIN 800-26.6 MG has declined 79.8%. It has been tracked across 235 weekly CMS publications since Feb 23, 2022.
What are the highest and lowest recorded NADAC prices for IBUPROFEN-FAMOTIDIN 800-26.6 MG?
Since Feb 23, 2022, the NADAC for IBUPROFEN-FAMOTIDIN 800-26.6 MG has ranged from a low of $0.6418 (Feb 18, 2026) to a high of $4.1664 (Nov 16, 2022), with a median of $1.6750 per EA.
Are there cheaper alternatives to IBUPROFEN-FAMOTIDIN 800-26.6 MG?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as IBUPROFEN-FAMOTIDIN 800-26.6 MG in a comparable dosage form, but none are currently priced below it.
Who manufactures IBUPROFEN-FAMOTIDIN 800-26.6 MG?
IBUPROFEN-FAMOTIDIN 800-26.6 MG (NDC 67877062690) is labeled by Ascend Laboratories, LLC, and CMS classifies it as a generic product.